CLINICAL TRIALS PROFILE FOR OXYCODONE AND ASPIRIN
✉ Email this page to a colleague
All Clinical Trials for OXYCODONE AND ASPIRIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00771758 ↗ | Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis | Completed | Grünenthal GmbH | Phase 3 | 2008-09-01 | The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate. |
NCT00771758 ↗ | Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis | Completed | Ortho-McNeil Janssen Scientific Affairs, LLC | Phase 3 | 2008-09-01 | The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate. |
NCT00814580 ↗ | Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery | Completed | Grünenthal GmbH | Phase 3 | 2008-12-01 | The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery. |
NCT00814580 ↗ | Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery | Completed | Ortho-McNeil Janssen Scientific Affairs, LLC | Phase 3 | 2008-12-01 | The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery. |
NCT01080677 ↗ | Caffeine/Propranolol Intervention for Acute Migraine | Completed | Stanford University | Phase 2 | 2007-01-01 | This is a research study to assess the safety of caffeine/propranolol at different dose levels. We want to find out what effects, good and/or bad, it has on patients and their migraines. |
NCT02160301 ↗ | Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients | Withdrawn | University of North Carolina, Chapel Hill | Phase 4 | 2017-11-01 | The study is a prospective, randomized, open-label comparison of a multimodal regimen and a standard, narcotic-based regimen for postoperative pain control in patients undergoing surgery for an operatively indicated, isolated extremity fracture. The investigators will be measuring pain levels, narcotic use, patient satisfaction, patient reported function, adverse events and fracture union. The investigators hypothesize that this multimodal regimen will lead to improved pain, less narcotic use and improved satisfaction as compared to the standard regimen. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OXYCODONE AND ASPIRIN
Condition Name
Clinical Trial Locations for OXYCODONE AND ASPIRIN
Trials by Country
Clinical Trial Progress for OXYCODONE AND ASPIRIN
Clinical Trial Phase
Clinical Trial Sponsors for OXYCODONE AND ASPIRIN
Sponsor Name